News
See our most recent product and company updates.
Wounded Police Dog Recovers with AlphaFlo®
In a remarkable case that highlights the dedication of veterinary professionals, a courageous police dog injured in the line of duty received expert care and support. The K9 officer was wounded in a shooting incident and was promptly taken to Doubletree Animal...
CASE STUDY: Oral Squamous Cell Carcinoma
Case Presentation: On February 8, 2024, an 8-year-old, spayed female Doberman Pinscher presented with a mass on the right craniolateral mandible. Biopsy samples revealed a squamous cell carcinoma. At the discretion of the veterinarian, 2.0 cc of AlphaFlo® was...
CASE STUDY: Chest Wound
Case Presentation: On May 4, 2022, a two-year-old, spayed female German Shepherd Mix presented with a large wound/ laceration on the sternum. On initial presentation, the patient required tension relieving sutures, as the wound could not be completely closed. The...
CASE STUDY: Calcanean Tendon Lesion (RH)
On September 20, 2021, a 5-year-old, male English Pointer presented with soft tissue swelling with heat noted on point of right hock. The patient was 2/5 lame with some abnormal foot placement with right hind foot. Patient was treated with Low Level Laser Therapy and...
CASE STUDY: Tibial Plateau Leveling Osteotomy
14 Client-owned dogs with naturally occurring rupture of the cranial cruciate ligament underwent Tibial Plateau Leveling Osteotomy (TPLO), performed by Mark Besancon, DVM. Of the 14 dogs, 7 received 1.0 cc of AlphaFlo® intra-articular after closing of the arthrotomy...
CASE STUDY: Acral Lick Dermatitis (LF)
Case Presentation: In January 2024, a 3-year-old Hound Mix dog presented with an erythematous and alopecic skin lesion on the carpal joint of the left front limb. The lesion was diagnosed as an acral lick dermatitis, and the...
Market Release of AlphaFlo® Canine Allograft
Equus Innovations, a manufacturer of advanced, next-generation veterinary regenerative products, in partnership with AlphaLogix, LLC (Argyle, Texas) announced today successful market release of a new canine allograft, AlphaFlo®.